These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison. Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347 [TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26). Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179 [TBL] [Abstract][Full Text] [Related]
12. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma. Leitha T; Walter R; Schlick W; Dudczak R Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945 [TBL] [Abstract][Full Text] [Related]
13. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma]. Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391 [TBL] [Abstract][Full Text] [Related]
14. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods]. Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937 [TBL] [Abstract][Full Text] [Related]
15. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study]. Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155 [TBL] [Abstract][Full Text] [Related]
16. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]. Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212 [TBL] [Abstract][Full Text] [Related]
17. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer. Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279 [TBL] [Abstract][Full Text] [Related]
18. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases]. Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409 [TBL] [Abstract][Full Text] [Related]
19. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value]. Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470 [TBL] [Abstract][Full Text] [Related]
20. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]